arrow
J

Jonas Kath

free university of berlin
H指数:9
被引数:324

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation

他克莫司抵抗性调节性T细胞的临床开发以实现同时免疫抑制和免疫调节

2026-05-012
OAAI
Lung tumouroids as a testing platform for precision CAR T cell therapy

肺部肿瘤作为精密CAR T细胞治疗的测试平台

2026-01-210
OAAI
mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells

mRNA介导的CAR T细胞工程:未经修饰的mRNA能够在不激活T细胞固有免疫的情况下实现高CAR表达

2026-01-050
OAAI
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors

个性化CRISPR敲入细胞因子基因疗法重塑肿瘤微环境并增强实体瘤中的CAR T细胞疗法

2025-12-090
OAAI
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model
2025-10-130
OAAI
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells ( vol 24 , 89 , 2023)

结合不同的CRISPR核酸酶以实现同时的基因敲入和碱基编辑,可防止多基因编辑CAR T细胞中的易位(卷24,期89,2023)

2025-03-260
OA
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer

CD3 epsilon基因编辑以重定向调节性T细胞用于过继性T细胞转移

2025-02-011
OAAI
Long-term in vitro maintenance of plasma cells in a hydrogel-enclosed human bone marrow microphysiological 3D model system

在水凝胶封闭的人骨髓微生理3D模型系统中长期体外维持浆细胞

2024-07-121
OA
Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency
2023-03-2411
OAAI